PL388511A1 - Method for securing solid form of a drug containing 4 - [(4-methylpiperazine-1-yl) methyl]-N-[4-methyl-3-[(4-pyridin-3-ylopirymidyn-2-yl) amino] phenyl] benzamide or its pharmaceutically acceptable forms or variations thereof - Google Patents

Method for securing solid form of a drug containing 4 - [(4-methylpiperazine-1-yl) methyl]-N-[4-methyl-3-[(4-pyridin-3-ylopirymidyn-2-yl) amino] phenyl] benzamide or its pharmaceutically acceptable forms or variations thereof

Info

Publication number
PL388511A1
PL388511A1 PL388511A PL38851109A PL388511A1 PL 388511 A1 PL388511 A1 PL 388511A1 PL 388511 A PL388511 A PL 388511A PL 38851109 A PL38851109 A PL 38851109A PL 388511 A1 PL388511 A1 PL 388511A1
Authority
PL
Poland
Prior art keywords
methyl
ylopirymidyn
methylpiperazine
benzamide
pyridin
Prior art date
Application number
PL388511A
Other languages
Polish (pl)
Other versions
PL231174B1 (en
Inventor
Andrzej Ostrowicz
Original Assignee
Biofarm Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofarm Spółka Z Ograniczoną Odpowiedzialnością filed Critical Biofarm Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL388511A priority Critical patent/PL231174B1/en
Publication of PL388511A1 publication Critical patent/PL388511A1/en
Publication of PL231174B1 publication Critical patent/PL231174B1/en

Links

PL388511A 2009-07-09 2009-07-09 Method for securing solid form of a drug containing 4 - [(4-methylpiperazine-1-yl) methyl]-N-[4-methyl-3-[(4-pyridin-3-ylopirymidyn-2-yl) amino] phenyl] benzamide or its pharmaceutically acceptable forms or variations thereof PL231174B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL388511A PL231174B1 (en) 2009-07-09 2009-07-09 Method for securing solid form of a drug containing 4 - [(4-methylpiperazine-1-yl) methyl]-N-[4-methyl-3-[(4-pyridin-3-ylopirymidyn-2-yl) amino] phenyl] benzamide or its pharmaceutically acceptable forms or variations thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL388511A PL231174B1 (en) 2009-07-09 2009-07-09 Method for securing solid form of a drug containing 4 - [(4-methylpiperazine-1-yl) methyl]-N-[4-methyl-3-[(4-pyridin-3-ylopirymidyn-2-yl) amino] phenyl] benzamide or its pharmaceutically acceptable forms or variations thereof

Publications (2)

Publication Number Publication Date
PL388511A1 true PL388511A1 (en) 2011-01-17
PL231174B1 PL231174B1 (en) 2019-01-31

Family

ID=43502724

Family Applications (1)

Application Number Title Priority Date Filing Date
PL388511A PL231174B1 (en) 2009-07-09 2009-07-09 Method for securing solid form of a drug containing 4 - [(4-methylpiperazine-1-yl) methyl]-N-[4-methyl-3-[(4-pyridin-3-ylopirymidyn-2-yl) amino] phenyl] benzamide or its pharmaceutically acceptable forms or variations thereof

Country Status (1)

Country Link
PL (1) PL231174B1 (en)

Also Published As

Publication number Publication date
PL231174B1 (en) 2019-01-31

Similar Documents

Publication Publication Date Title
TWI367212B (en) Dosage forms of palonosetron hydrochloride having improved stability and bioavailability
HK1220902A1 (en) Pharmaceutical dosage form for oral administration of a bcl-2 family inhibitor bcl-2
IL206201A0 (en) Pharmaceutically acceptable salts of 2-{4-[(3s)-piperidin-3-yl]phenyl}-2h-indazole-7-carboxamide
PT2588090T (en) Pharmaceutical oral dosage forms comprising dabigatran etexilate and its pharmaceutically acceptable salts
HU0600816D0 (en) Method of alcohol-induced dose dumping for opioid sustained release oral dosage forms
CL2007002930A1 (en) A COMPOUND 4- [4 - ({[4-CHLORINE-3- (TRIFLUOROMETIL) PHENYL] CARBAMOIL} AMINO) -3-FLUOROFENOXI] -N-METHYLPIRIDIN-2-CARBONXAMIDE MONOHIDRATADO; PREPARATION PROCESS; COMPOSITION AND PHARMACEUTICAL COMBINATION; AND USE FOR THE TREATMENT OF HYPERPROLIFERATI DISORDERS
IL211099A0 (en) Formulation for oral administration of proteins
IL211279A (en) Use of a tspan12 antagonist in the manufacture of a medicament for inhibiting ocular angiogensis
HRP20130394T1 (en) Process for the preparation of piperazine compounds and hydrochloride salts thereof
ZA200610770B (en) Dosage form for delivery of multiple drug forms
IL177402A0 (en) Composition for oral administration of tamsulosin hydrochloride
EP2588106A4 (en) Sustained-release pharmaceutical composition containing pramipexole or pharmaceutically acceptable salt thereof with improved stability
HK1170908A1 (en) Novel compounds and therapeutic use thereof for protein kinase inhibition
HK1208156A1 (en) Once-a-day replacement transdermal administration of fentanyl
EP2456439A4 (en) A stable pharmaceutical omeprazole formulation for oral administration
MA33883B1 (en) The process of formation and crystalline form of hydrochloride 4} 3] c-hexanhydrochlopitan [c] pyrrol-2 (1h)-[yl propoxy {benzamide and the pharmaceutical formulations it contains
ZA201402756B (en) Immediate release 4-methyl-3-[[4-(3-pyridinyl)]amino]-n-[5-(4-methyl- 1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl]benzamide formulation
PT2065317E (en) Method for storing packets of medicine
PL388511A1 (en) Method for securing solid form of a drug containing 4 - [(4-methylpiperazine-1-yl) methyl]-N-[4-methyl-3-[(4-pyridin-3-ylopirymidyn-2-yl) amino] phenyl] benzamide or its pharmaceutically acceptable forms or variations thereof
FI7357U1 (en) A Method for Reducing Alcohol-Induced Dose Discharge for Long-acting Oral Dosage Forms of Opioids
PL394559A1 (en) Capsules containing 4-[(4-methylopiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylopyrimidin-2-yl)amine]phenyl]benzamide and process for the preparation thereof
PL387516A1 (en) Pharmaceutical composition containing 4-[(4-metyl piperazine-1-yl)methyl]-N-[4-methyl-3-[(4-pyridine-3-yl pyrimidin-2-yl)amino]phenyl]benzamide, method of its manufacturing and the forms of the medicine containing this composition
SI2125761T1 (en) Novel process for synthesis of pramipexole and its pharmaceutically acceptable salts
PL392269A1 (en) Tablet containing 4-[(4-methylopiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylopyrimidin-2-yl)amine]phenyl]benzamide and process for the preparation thereof
EP2465503A4 (en) Pharmaceutical solution of cetirizine hydrochloride